Essential hypertension in adolescents.
D000293:Adolescent; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D002648:Child; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects; D004039:Diet, Sodium-Restricted; D004232:Diuretics / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006145:Guanethidine / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D006977:Hypertension, Renal / Q000188:drug therapy; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D009820:Ohio; D011336:Probability; D011433:Propranolol / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use
D000959:Antihypertensive Agents; D003280:Contraceptives, Oral, Synthetic; D004232:Diuretics; D006830:Hydralazine; D008750:Methyldopa; D012110:Reserpine; D011433:Propranolol; D006145:Guanethidine